Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitro

QR Code

Antiviral effects of mogroside V against porcine reproductive and respiratory syndrome virus in vitro

Porcine reproductive and respiratory syndrome virus (PRRSV) infection has inflicted devastating impacts on the global swine industry, while current vaccines provide limited protection against this disease. Mogroside V (MV), a triterpenoid compound derived from Siraitia grosvenorii, exhibits diverse...

Full description

Saved in:

Bibliographic Details
Main Authors:	Longhua Liang, Xiaohui Huang, Guoxi Qin, Xiaoyu Ma, Rijing He, Hongpeng Dai, Zhen Zhang, Xiaogan Yang, Xingwei Liang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Microbiology
Subjects:	PRRSV mogroside V antiviral action antioxidant cytokines
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2025.1611600/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification of compounds targeting porcine reproductive and respiratory syndrome virus nsp3 and evaluation of their antiviral efficacy
by: Zhan He, et al.
Published: (2025-12-01)

The Virosome as a Novel Concept for High Pathogenic Porcine Reproductive and Respiratory Syndrome Virus (HP-PRRSV) Vaccines
by: Zheng CAO, et al.
Published: (2013-07-01)

Purification of <i>Mogroside V</i> from Crude Extract of <i>Siraitia grosvenorii</i> Using Boronic Acid-Functionalized Silica Gel and Its Hypoglycemic Activity Determination
by: Yanmei Xu, et al.
Published: (2025-05-01)

Changes in Saliva Analytes in Pigs in Different Clinical Situations from Farms Positive to Porcine Reproductive and Respiratory Syndrome (PRRS): A Pilot Study
by: Eva Llamas-Amor, et al.
Published: (2025-06-01)

Challenges and Lessons Learned from a Field Trial on the Understanding of the Porcine Respiratory Disease Complex
by: Elisa Crisci, et al.
Published: (2025-07-01)

The cellular interactome for glycoprotein 5 of the Chinese highly pathogenic porcine reproductive and respiratory syndrome virus
by: Ji-ge DU, et al.
Published: (2016-08-01)

Isolation and Biological Characteristics Study of Porcine Reproductive and Respiratory Syndrome Virus GZ2022 Strain
by: Xinmei Yang, et al.
Published: (2025-07-01)

Assessing the effect of orally administered Ivermectin on viremia and shedding of porcine reproductive and respiratory syndrome virus in growing pigs under field conditions
by: Grant Allison, et al.
Published: (2025-07-01)

Functional Characterization of Squalene Epoxidases from <i>Siraitia grosvenorii</i>
by: Huan Zhao, et al.
Published: (2025-06-01)

Epidemiology and genetic characterization of porcine reproductive and respiratory syndrome virus in Fujian Province, China, from 2023 to 2024
by: Long-Bin Kang, et al.
Published: (2025-07-01)

Glycosylation of canine tetherin is essential for its antiviral activity against H3N2 canine influenza virus
by: Liang Xu, et al.
Published: (2025-07-01)

Isolation and pathogenicity of the novel porcine reproductive and respiratory syndrome virus 1 strain ZJ01 in South China
by: Bohua Ren, et al.
Published: (2025-07-01)

Identification of the strain-specifically truncated nonstructural protein 10 of porcine reproductive and respiratory syndrome virus in infected cells
by: Zhi-bang ZHANG, et al.
Published: (2018-05-01)

Complete Genome and Recombination Analysis of a Novel Porcine Reproductive and Respiratory Syndrome Virus 2 (Variant 1H.18) Identified in the Midwestern USA
by: Joao P. Herrera da Silva, et al.
Published: (2025-06-01)

Natural mutations in key NLS amino acids regulate nucleoplasmic shuttling and replication efficiency in PRRSV
by: Xianchang Zhu, et al.
Published: (2025-07-01)

Antiviral compounds from plants /
by: Hudson, James B.
Published: (1989)

Effect of Pooling and Freeze-Thaw Processes on the PRRSV RNA Detection in TOSc Samples
by: Peng Li, et al.
Published: (2025-06-01)

THAP11-mediated K48- and K63-linked ubiquitination is essential for the degradation of porcine reproductive and respiratory syndrome virus nonstructural protein 1β
by: Binghua Chen, et al.
Published: (2025-06-01)

Epidemiological Review of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in Japan: From Discovery and Spread to Economic Losses and Future Prospects
by: Osamu Taira, et al.
Published: (2025-06-01)

Antiviral Properties of Basidiomycetes Metabolites
by: A. V. Avtonomova, et al.
Published: (2020-05-01)

Critical role of cytochrome c1 and its cleavage in porcine reproductive and respiratory syndrome virus nonstructural protein 4-induced cell apoptosis via interaction with nsp4
by: Feng ZHANG, et al.
Published: (2017-11-01)

Pig macrophages with site-specific edited CD163 decrease the susceptibility to infection with porcine reproductive and respiratory syndrome virus
by: Kui XU, et al.
Published: (2023-07-01)

In Silico Designed Multi-Epitope Vaccine Based on the Conserved Fragments in Viral Proteins for Broad-Spectrum Protection Against Porcine Reproductive and Respiratory Syndrome Virus
by: Shaukat Ullah, et al.
Published: (2025-06-01)

Development of a Quadruplex RT-qPCR Assay for Rapid Detection and Differentiation of PRRSV-2 and Its Predominant Genetic Sublineages in China
by: Guishan Ye, et al.
Published: (2025-06-01)

Investigation on the co-infections of Toxoplasma gondii with PRRSV, CSFV or PCV-2 in swine in part of China
by: Shuai WANG, et al.
Published: (2015-09-01)

Outcomes of liver transplantation in the era of modern antiviral therapy for hepatitis C
by: K. Yu. Kokina, et al.
Published: (2021-04-01)

Longitudinal Monitoring of Mono- and Coinfections Involving Primary Porcine Reproductive Viruses (PCV2, PPV1, and PRRSV) as Well as Emerging Viruses (PCV3, PCV4, and nPPVs) in Primiparous and Multiparous Sows and Their Litters
by: Diana S. Vargas-Bermudez, et al.
Published: (2025-06-01)

T cell epitope content comparison using EpiCC correlates with vaccine efficacy against heterologous porcine reproductive and respiratory syndrome virus type 2 strains
by: J. Mark Hammer, et al.
Published: (2025-06-01)

Mogrosides Protect Against Diabetic Kidney Injury via Inhibiting Macrophage Activation in a Mouse Model
by: Fangyi Jiang, et al.
Published: (2025-01-01)

Can biopolymers act as antiviral agents?
by: J. Seppala, et al.
Published: (2020-11-01)

Antiviral Activity of Panavir in Experimental Infection Due to Morbillivirus in Cell Cultures
by: S. G. Markushin, et al.
Published: (2020-05-01)

Antiviral Action of Sulfated Polysaccharides
by: I. D. Makarenkova, et al.
Published: (2020-05-01)

EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2015-09-01)

Spatiotemporal Regulation of STING Activity by Linear Ubiquitination Governs Antiviral Immunity
by: Yong Zhang, et al.
Published: (2025-07-01)

Progress in the development and application of plant-based antiviral agents
by: Xiang-yang LI, et al.
Published: (2017-12-01)

SOME ASPECTS OF THE MARKETING STUDIES FOR THE PHARMACEUTICAL MARKET OF ANTIVIRAL DRUGS
by: A. G. Salnikova, et al.
Published: (2015-12-01)

Kaempferol inhibits Pseudorabies virus replication in vitro through regulation of MAPKs and NF-κB signaling pathways
by: Xu CHEN, et al.
Published: (2021-08-01)

Study of the Antiviral Activity of Adamantane-Containing Chemical Compounds
by: I. I. LYUBIMOV, et al.
Published: (2022-11-01)

Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection
by: E. N. Bessonova
Published: (2011-06-01)

Significant Increase of Cinnamic Acid in Metabolites of Chicks Infected with Infectious Bronchitis Virus and Its Remarkable Antiviral Effects In Vitro and In Vivo
by: Lan-Ping Wei, et al.
Published: (2025-07-01)